SNESSNESBasic Materials · Specialty Chemicals

SNES Stock Forecast: SenesTech, Inc. Price Predictions for 2026-2027

Last close, 2 Oct 2026
$0.78
+16.27% on the day

The 1 Wall Street analysts covering SenesTech, Inc. hold a median 12-month price target of $6.75 — +766.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 29 of 100 as at 2 Oct 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$3.6M
Ticker Nerd rank
29 / 100
Median analyst target
$6.75
Analysts covering
1
Revenue$770K+23.2% y/y
Operating income−$1.9M
Net income−$1.8M
Free cash flow−$1.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+9.1%
1M
−26.5%
YTD
−63.6%
1Y
−80.2%
From 52W high
−82.0%
From 52W low
+23.3%
$0.63
$4.33
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SNES stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SenesTech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Oct 2026
29 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
97
Revisions
67
Accruals
46
Quality
40
Issuance
39
Growth
30
Volatility
17
Value
12
Momentum
12

Size (97): Smaller than most of the companies we track.

Momentum (12): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SNES stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SNES, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$2.00$4.00$6.00$8.00$10.00Jan 26Apr 26Jul 26Oct 26SNESHigh $10.00Median $6.75Low $3.50

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Low $3.50Median $6.75High $10.00

The green dot is the last close — the median target sits +766.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
13 Dec 2024HC Wainwright & Co.ReiteratesBuy$3.50 → $10
12 Dec 2024HC Wainwright & Co.MaintainsBuy$3.50 → $10
14 May 2024HC Wainwright & Co.ReiteratesBuy—
28 Dec 2023HC Wainwright & Co.MaintainsBuy—
24 May 2023HC Wainwright & Co.ReiteratesBuy$4.00
18 Apr 2023HC Wainwright & Co.ReiteratesBuy$4.00
20 Jan 2021HC Wainwright & Co.InitiatesBuy$4.00
25 Nov 2020Craig-HallumInitiatesBuy—
4 Jan 2017Craig-HallumInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SNES appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

SNES vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, SenesTech, Inc. returned −80.2% against +16.2% for the S&P 500, dividends included.

SNES vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26SNESS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SNES analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

SenesTech, Inc. (SNES) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.0×

Cheaper than 74% of US stocks

Price / sales
1.5×

Cheaper than 59% of US stocks

Price / book
0.6×

Cheaper than 82% of US stocks

EV / EBITDA
−0.2×

Cheaper than 62% of US stocks

Growth & margins
Revenue growth (YoY)
23.2%

Higher than 72% of US stocks

Earnings growth (YoY)
23.2%

Higher than 61% of US stocks

Gross margin
73.6%

Higher than 86% of US stocks

Operating margin
−241.8%

Higher than 10% of US stocks

Net margin
−294.7%

Higher than 1% of US stocks

Returns & dividend
Return on equity
−107.4%

Higher than 13% of US stocks

Return on assets
−45.5%

Higher than 9% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

SenesTech, Inc. (SNES) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • SenesTech, Inc. has a market value of $3.6M and an enterprise value of $1.1M.

  • Revenue in the twelve months to 30 June 2026: $2.4M. The latest quarter grew 23.2% year on year.

  • Net income over the same four quarters: −$7.0M, a −294.7% net margin.

  • Diluted earnings per share, trailing twelve months: $−1.37.

  • Free cash flow in the twelve months to 30 June 2026: −$6.7M.

  • Shares outstanding: 5.3M.

  • Trailing P/E: 0.0×; forward P/E: −0.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • SenesTech, Inc. employs 23 people — $103K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 2 Oct 2026

Data provided by Twelve Data

Peers

SNES vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
SNESSenesTech, Inc.$3.6M
29
CNEYCN Energy Group, Inc.$4.4M
19
BGLCBioNexus Gene Lab Corp.$3.7M
24
YMATJ-Star Holding Co., Ltd.$5.8M
13
BONBon Natural Life Ltd.$9.3M
21
LOOPLoop Industries, Inc.$21.4M
16
CITRCitroTech, Inc.$65.9M
33

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own SenesTech, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SNES news & analysis

SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers

PRNewsWire · 23 Sept 2026positive

SenesTech announced that its Evolve® rodent birth control products will soon be available through Grove Collaborative's online marketplace, expanding the company's third-party e-commerce distribution to sustainability-focused consumers.

Why it matters — This expansion broadens SenesTech's retail reach and introduces its products to a new audience that aligns with its sustainable rodent management positioning, potentially growing sales channels for SNES watchers.

SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference

PRNewsWire · 17 Sept 2026neutral

SenesTech, Inc., a leader in rodent birth control and sustainable rodent population management, announced it will participate in the Lytham Partners Fall 2026 Investor Conference, which is being held virtually on September 29-30, 2026. The company will deliver a webcast presentation and host one-on-one meetings with investors during the event.

Why it matters — The conference participation gives SenesTech a platform to present its business directly to investors, which SNES watchers may view as an opportunity for increased visibility and engagement.

Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat

PRNewsWire · 31 Aug 2026positive

SenesTech announced that a six-month deployment of its Evolve® Rat product as part of an Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts.

Why it matters — This municipal deployment result provides real-world evidence of Evolve® Rat's effectiveness, which could support broader adoption of SenesTech's rodent control solutions.

SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PRNewsWire · 27 Aug 2026neutral

SenesTech announced that its Board of Directors granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales. The grant was made under Nasdaq Listing Rule 5635(c)(4).

Why it matters — A SNES watcher would care as this marks a notable addition to the company's senior sales leadership, which could bear on the company's commercial efforts.

FAQ

Frequently asked questions about SNES stock

What is the SNES stock price forecast for 2026-2027?

The 1 Wall Street analysts covering SenesTech, Inc. have a median 12-month price target of $6.75, with estimates ranging from $3.5 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SNES stock a buy right now?

Of the 1 analysts covering SenesTech, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SenesTech, Inc. 29 out of 100 across roughly 4,600 US stocks as at 2 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SNES?

As at 2 Oct 2026, SenesTech, Inc. ranks 29 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).

Will SNES stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +766.5% from the last close, and Ticker Nerd's factor model ranks SenesTech, Inc. 29 out of 100 as at 2 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SNES stock forecast for 2030?

No analyst covering SenesTech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SNES are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3.5 to $10 over the next 12 months.

How has SNES stock performed over the past year?

SenesTech, Inc. returned -80.2% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does SenesTech, Inc. do?

SenesTech, Inc. is a biotechnology company focused on fertility-based pest management for rats and mice.

What is the latest news on SNES?

The most recent item we track (PRNewsWire, 23 Sept 2026): "SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers". SenesTech announced that its Evolve® rodent birth control products will soon be available through Grove Collaborative's online marketplace, expanding the company's third-party e-commerce distribution to sustainability-focused consumers.

Company

About SenesTech, Inc.

SenesTech, Inc. is a biotechnology company focused on fertility-based pest management for rats and mice. The company develops and commercializes non-lethal rodent control products designed to reduce reproduction and help manage animal pest populations. Its current product line includes ContraPest, a liquid bait used for rat population control, Evolve, a soft bait for rats, and Evolve Mouse, a bait formulation for mice. SenesTech also provides teleconsulting and technical advisory services to support pest management programs. The company’s solutions are used in commercial, agricultural, and urban settings where controlling rodent activity is important for sanitation, property protection, and operational reliability. Headquartered in Phoenix, Arizona, SenesTech positions fertility control as an alternative approach within the broader pest management market.

CEO Mr. Michael Edell · 23 employees · United States · https://www.senestech.com